Literature DB >> 31049602

[Anesthesiological aspects of liver transplantation].

S Dehne1, F Lund1, J Larmann1, K Schmidt1, T Brenner1, M A Weigand1, R von Haken2.   

Abstract

Liver transplantation (LTPL) is the only curative option for patients with end stage liver disease (ESLD) or with hepatocellular carcinoma (HCC). Eurotransplant in Leiden, the Netherlands, is responsible for organ allocation. The model of end stage liver disease (MELD) score, which describes the severity of the liver disease, is decisive for organ allocation. The heterogeneous patient collective and hepatic-related comorbidities and their dynamics represent challenges. The anesthesiologist is responsible for evaluating the overall prognosis, whereby cardiac, pulmonary, renal and neurological comorbidities must be taken into consideration. During LTPL surgery is divided into several stages. Besides volume management, heat preservation and coagulation management, major challenges for the anesthesiologist are hemodynamic stabilization and regulation of the acid-base balance.

Entities:  

Keywords:  Acid-base equilibrium; End stage liver disease; Hemodynamics; Portal hypertension; Water-electrolyte balance

Year:  2019        PMID: 31049602     DOI: 10.1007/s00101-019-0595-x

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  67 in total

1.  Postoperative tracheal extubation after orthotopic liver transplantation.

Authors:  M Glanemann; J Langrehr; U Kaisers; R Schenk; A Müller; B Stange; U Neumann; W O Bechstein; K Falke; P Neuhaus
Journal:  Acta Anaesthesiol Scand       Date:  2001-03       Impact factor: 2.105

Review 2.  [Portal hypertension].

Authors:  R Wiest; G Lock; J Schölmerich
Journal:  Internist (Berl)       Date:  2000-10       Impact factor: 0.743

Review 3.  [The pulmonary artery catheter].

Authors:  W Zink; B M Graf
Journal:  Anaesthesist       Date:  2001-08       Impact factor: 1.041

4.  Intraoperative management of severe pulmonary hypertension during cardiac surgery with inhaled iloprost.

Authors:  Steffen Rex; Thomas Busch; Manfred Vettelschoss; Lothar de Rossi; Rolf Rossaint; Wolfgang Buhre
Journal:  Anesthesiology       Date:  2003-09       Impact factor: 7.892

5.  Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula.

Authors:  Richard B Freeman; Robert G Gish; Ann Harper; Gary L Davis; John Vierling; Leslie Lieblein; Goran Klintmalm; Jamie Blazek; Robert Hunter; Jeffrey Punch
Journal:  Liver Transpl       Date:  2006-12       Impact factor: 5.799

Review 6.  Finding a place for public preferences in liver allocation decisions.

Authors:  J Neuberger; P A Ubel
Journal:  Transplantation       Date:  2000-11-27       Impact factor: 4.939

Review 7.  Hyponatremia in cirrhosis: pathogenesis, clinical significance, and management.

Authors:  Pere Ginès; Mónica Guevara
Journal:  Hepatology       Date:  2008-09       Impact factor: 17.425

8.  Risk factors and impact of chronic obstructive pulmonary disease in candidates for liver transplantation.

Authors:  Debbie Rybak; Michael B Fallon; Michael J Krowka; Robert S Brown; Jenna Reinen; Linda Stadheim; Dorothy Faulk; Carrie Nielsen; Nadine Al-Naamani; Kari Roberts; Steven Zacks; Ted Perry; James Trotter; Steven M Kawut
Journal:  Liver Transpl       Date:  2008-09       Impact factor: 5.799

9.  Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients.

Authors:  D L Russell; A Flood; T E Zaroda; C Acosta; M M S Riley; R W Busuttil; D A Pegues
Journal:  Am J Transplant       Date:  2008-06-28       Impact factor: 8.086

10.  Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America.

Authors:  Joseph S Solomkin; John E Mazuski; John S Bradley; Keith A Rodvold; Ellie J C Goldstein; Ellen J Baron; Patrick J O'Neill; Anthony W Chow; E Patchen Dellinger; Soumitra R Eachempati; Sherwood Gorbach; Mary Hilfiker; Addison K May; Avery B Nathens; Robert G Sawyer; John G Bartlett
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.